A nonhydrolyzable candesartan cilexetil analog reveals synergistic activation as a tractable mechanism for TMEM175 modulation
American Journal of Physiology-Cell Physiology · 01.08.2026 · 331 (2) · C415-C424
DOI: 10.1152/ajpcell.00348.2026 ↗Kurz gefasst
Fachartikel in der Zeitschrift American Journal of Physiology-Cell Physiology, erschienen am 01.08.2026. Verfasst von Kangjun Li und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacology, Vanderbilt University, Nashville, Tennessee, United States. Hauptthemen laut MEDLINE: Benzimidazoles, Biphenyl Compounds, Tetrazoles. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 38 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NCATS NIH HHS, HHS | National Institutes of Health (NIH), NIH HHS.
Abstract (Originalsprache)
We introduce a new therapeutic paradigm for TMEM175 targeting by demonstrating that synergistic agonist pairs can drive robust channel activation. Beyond identifying candesartan cilexetil as a moderately potent activator with a previously unrecognized pharmacophoric cilexetil moiety, we show that a minimally active analog can dramatically potentiate activation in combination with DCPIB. This synergistic strategy establishes TMEM175 as a tractable therapeutic target and reveals coagonism as a powerful mechanism to modulate lysosomal ion channels.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pharmacology, Vanderbilt University, Nashville, Tennessee, United States.
- Department of Anesthesiology, Vanderbilt University Medical Center, Nashville, Tennessee, United States.
- Vanderbilt Institute of Chemical Biology, Vanderbilt University, Nashville, Tennessee, United States.
- Department of Chemistry, Vanderbilt University, Nashville, Tennessee, United States.
ORCID-Profile: Samantha D Le, Ian M Romaine, Kwangho Kim, Alex G Waterson, Jerod S Denton
Förderung
- NCATS NIH HHS
- HHS | National Institutes of Health (NIH)
- NIH HHS
Zitieren
APA
Li, K., Le, S. D., Satpute Janve, V., Lazarenko, R. M., Romaine, I. M., Kim, K., Sulikowski, G. A., Waterson, A. G., & Denton, J. S. (2026). A nonhydrolyzable candesartan cilexetil analog reveals synergistic activation as a tractable mechanism for TMEM175 modulation. American Journal of Physiology-Cell Physiology, 331(2), C415-C424. https://doi.org/10.1152/ajpcell.00348.2026
Vancouver
Li K, Le SD, Satpute Janve V, Lazarenko RM, Romaine IM, Kim K, et al. A nonhydrolyzable candesartan cilexetil analog reveals synergistic activation as a tractable mechanism for TMEM175 modulation. American Journal of Physiology-Cell Physiology. 2026;331(2):C415-C424. doi:10.1152/ajpcell.00348.2026
BibTeX
@article{Li2026,
author = {Li, Kangjun and Le, Samantha D and Satpute Janve, Vaishali and Lazarenko, Roman M and Romaine, Ian M and Kim, Kwangho and Sulikowski, Gary A and Waterson, Alex G and Denton, Jerod S},
title = {A nonhydrolyzable candesartan cilexetil analog reveals synergistic activation as a tractable mechanism for TMEM175 modulation},
journal = {American Journal of Physiology-Cell Physiology},
year = {2026},
volume = {331},
number = {2},
pages = {C415--C424},
doi = {10.1152/ajpcell.00348.2026}
}
EUVIMED